Clinical Trial Update: Role of Oxytocin in Telling and Detecting Lies [EARLY_Phase 1]

View source ↗

Summary

An EARLY Phase 1 clinical trial assessing oxytocin's role in telling and detecting lies, conducted for dyssocial behavior, has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyssocial Behavior

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of Texas at Austin | Conditions: Dyssocial Behavior | EARLY_Phase 1 | Status: WITHDRAWN